Corcept Therapeutics Incorporated shares owned by Citigroup
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $14M | 284k | 50.39 |
| 2024-09-30 | $9.5M | 204k | 46.28 |
| 2024-06-30 | $3.1M | 96k | 32.49 |
| 2024-03-31 | $3.7M | 148k | 25.19 |
| 2023-12-31 | $4.0M | 123k | 32.48 |
| 2023-09-30 | $3.0M | 112k | 27.25 |
| 2023-03-31 | $2.9M | 133k | 21.65 |
| 2022-12-31 | $1.5M | 75k | 20.31 |
| 2022-09-30 | $3.7M | 151k | 24.39 |
| 2021-12-31 | $1.8M | 90k | 19.80 |
| 2021-03-31 | $951k | 40k | 23.81 |
| 2020-12-31 | $2.7M | 99k | 26.94 |
| 2020-09-30 | $2.4M | 137k | 17.33 |
| 2020-06-30 | $3.1M | 186k | 16.84 |
| 2020-03-31 | $1.7M | 141k | 11.83 |
| 2019-12-31 | $4.1M | 331k | 12.35 |
| 2019-09-30 | $3.3M | 231k | 14.18 |
| 2019-06-30 | $2.3M | 203k | 11.15 |
| 2019-03-31 | $0 | 282k | 0.00 |
| 2018-12-31 | $4.9M | 362k | 13.40 |
| 2018-09-30 | $1.8M | 127k | 14.06 |
| 2018-06-30 | $4.2M | 266k | 15.72 |
| 2018-03-31 | $4.0M | 247k | 16.36 |
| 2017-12-31 | $6.1M | 338k | 18.06 |
| 2017-09-30 | $4.7M | 245k | 19.30 |
| 2017-06-30 | $2.1M | 175k | 11.80 |
| 2017-03-31 | $288k | 26k | 10.96 |
| 2016-12-31 | $549k | 76k | 7.26 |
| 2016-09-30 | $169k | 26k | 6.51 |
| 2016-06-30 | $88k | 16k | 5.49 |
| 2015-12-31 | $146k | 29k | 4.99 |
| 2015-09-30 | $0 | 10 | 0.00 |
| 2015-06-30 | $5.0k | 804 | 6.22 |
| 2014-09-30 | $5.0k | 1.9k | 2.70 |
| 2014-03-31 | $38k | 8.8k | 4.38 |
| 2013-12-31 | $54k | 17k | 3.25 |
| 2013-09-30 | $0 | 71 | 0.00 |
| 2013-06-30 | $0 | 70 | 0.00 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated